Cost-Effective Clinical Validation Reshapes Biotech Development Timeline
Cost-Effective Clinical Validation Reshapes Biotech Development TimelineThe biotechnology sector faces mounting pressure to reduce clinical trial costs while maintaining scientific rigor. Recent data suggests that conducting trials in certain international markets can reduce expenses by 80-90% compared to traditional Western pathways, a strategy that Dutch-founded Celljevity has leveraged to accelerate its regenerative medicine...